Shenzhen listed Hubei Biocause Pharmaceutical has announced that it plans to merge with Guohua Life with the merged entity to adopt the insurer's name.
Please login to read the full news
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »